Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media’s Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was a qui tam case where Sheller, P.C. represented the whistleblower who brought the qui tam charges. With the U.S. Department of Justice, the Sheller firm achieved this settlement recovering the $2.2 billion on behalf of taxpayers and the government to settle the allegations the drug company misled, illegally marketed and made False Claims for the sales of drugs to government health programs. See J&J Will Pay More Than $2.2 Billion To Settle U.S. Cases in Bloomberg News (November 4, 2013).
The firm also had number 23, with the U.S. Government settling allegations of illegal marketing against Astellas Pharma for their promotion of ADHD drugs for unapproved uses including how the drugs could make the children who took it “better students” among other things. See Astellas Pharma US settles Mycamine False Claims Act case for $7.3 million in the Pennsylvania Record (April 17, 2014).
Links
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes: Deal with Justice Department Regards Drug Maker’s Selling of Antipsychotic Risperdal, The Wall Street Journal, November 4, 2013 (Subscription required)
